Drug profile · INN
pegzilarginase-nbln
LOARGYS
pegzilarginase-nbln (LOARGYS) is a l-arginine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Drug details — pegzilarginase-nbln
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
pegzilarginase-nbln (LOARGYS) is a l-arginine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
L-arginine hydrolytic enzyme
Primary target: L-arginine
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is pegzilarginase-nbln?
pegzilarginase-nbln (LOARGYS) is a l-arginine hydrolytic enzyme. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for pegzilarginase-nbln?
LOARGYS is a marketed brand name for pegzilarginase-nbln. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of pegzilarginase-nbln?
pegzilarginase-nbln has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.